
    
      Will be included women aged between 18 and 65 years, chronic pain fibromyalgia according to
      the criteria of the American College of Rheumatology, pain unresponsive to analgesics such as
      paracetamol, acetylsalicylic acid, ibuprofen, Carisoprodol, Zanaflex (Tizanidine) and Codeine
      and give informed consent to participate after initial evaluation. Primary outcome is to
      Evaluate whether the tDCS associated with cognitive retraining technique is able to modulate
      attentional bias in fibromyalgia patients. Secondary outcomes are: compare the effect of
      active tDCS and sham in: Assessed with the Visual Analog Scale for 8 days, Functional
      capacity, Conditional pain modulation (CPM), Maximal Heat Pain tolerance,Catastrophic
      thinking,Serum levels of Brain Derived Neurotrophic Factor (BDNF), Beck Depression Inventory,
      forward and backward digit span( WAIS),Pittsburgh sleep quality and State-Trait Anxiety
      Inventory (STAI) test.
    
  